Nichi-iko Pharmaceutical Co. Ltd. | Mutual Funds
Mutual Funds that own Nichi-iko Pharmaceutical Co. Ltd.
Nomura Asset TOPIX ETF Fund (1306)
832,700
1.37%
13,200
0.02%
07/31/2018
Vanguard Total International Stock Index Fund
654,395
1.08%
0
0%
07/31/2018
Daiwa Asset TOPIX Listed ETF (1305)
408,700
0.67%
8,300
0.02%
07/31/2018
Government Pension Fund - Global (The)
377,699
0.62%
-182,114
0%
12/31/2017
Nikko Asset Listed Index TOPIX ETF (1308)
375,000
0.62%
0
0.02%
08/20/2018
AXA Framlington Health Fund
315,500
0.52%
-4,100
0.65%
04/30/2018
DFA Japanese Small Company Series
301,550
0.5%
32,700
0.11%
01/31/2018
iShares MSCI EAFE Small Cap ETF
253,700
0.42%
0
0.04%
09/06/2018
Vanguard Developed Markets Index Fund
238,400
0.39%
0
0%
07/31/2018
DFA International Core Equity Portfolio
224,750
0.37%
43,200
0.01%
04/30/2018
| Address |
1-6-21 Sogawa
Toyama Toyama 930
Japan
|
|
Employees
|
- |
| Website |
http://www.nichiiko.co.jp |
| Updated |
07/08/2019 |
| Nichi-Iko Pharmaceutical Co., Ltd. develops, manufactures, and markets generic pharmaceutical products. Its products are classified into Prescriptive and General Over-the-Counter (OTC) drugs. These products are used for the treatment of circulatory, digestive, respiratory, central and peripheral nervous systems problems. |
